Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Total Liabilities (2019 - 2023)

Historic Total Liabilities for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $521.1 million.

  • ADC Therapeutics' Total Liabilities rose 2203.99% to $521.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $521.1 million, marking a year-over-year increase of 2203.99%. This contributed to the annual value of $411.4 million for FY2022, which is 1057.91% up from last year.
  • Latest data reveals that ADC Therapeutics reported Total Liabilities of $521.1 million as of Q3 2023, which was up 2203.99% from $515.9 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Total Liabilities peaked at $177.5 billion during Q2 2020, and registered a low of $26.5 million during Q4 2019.
  • In the last 5 years, ADC Therapeutics' Total Liabilities had a median value of $423.1 million in 2022 and averaged $23.4 billion.
  • As far as peak fluctuations go, ADC Therapeutics' Total Liabilities crashed by 9987.58% in 2021, and later surged by 15603.19% in 2022.
  • Quarter analysis of 5 years shows ADC Therapeutics' Total Liabilities stood at $26.5 million in 2019, then skyrocketed by 548294.03% to $145.5 billion in 2020, then plummeted by 99.74% to $372.0 million in 2021, then grew by 10.58% to $411.4 million in 2022, then rose by 26.66% to $521.1 million in 2023.
  • Its Total Liabilities stands at $521.1 million for Q3 2023, versus $515.9 million for Q2 2023 and $430.0 million for Q1 2023.